Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL1000017	注射用重组人B淋巴细胞刺激因子受体-抗体融合蛋白	Lyophilized	Biological Products(1)	New Drug Application	2010-07-01	烟台荣昌生物工程有限公司	RemeGen Co Ltd	Certificate Issued	2011-04-21	view
CYSB1300034	注射用重组人B淋巴细胞刺激因子受体-抗体融合蛋白	Lyophilized	Biological Products	Supplementary Application	2013-03-14	烟台荣昌生物工程有限公司	RemeGen Co Ltd	Certificate Issued	2013-07-19	view
CXSB1600007	注射用重组人B淋巴细胞刺激因子受体-抗体融合蛋白	Lyophilized	Biological Products	Supplementary Application	2016-10-11	烟台荣昌生物工程有限公司	RemeGen Co Ltd	Certificate Issued	2017-04-17	view
CXSL1700191	注射用重组人B淋巴细胞刺激因子受体－抗体融合蛋白	Lyophilized	Biological Products(1)	New Drug Application	2018-01-08	荣昌生物制药（烟台）有限公司	RemeGen Co Ltd	Certificate Issued	2018-06-08	view